2025 Panellists

Presenters will receive direct feedback from a panel of investment professionals with decades of experience in research translation and pharmaceutical investment.

Prashanth Rajan

Investment Analyst
Brandon Capital

Kathy Connell

Non Executive Director
Avecho Biotechnology

Wolfgang Jarolimek

Head of Drug Discovery
Syntara

Phil Kearney

CEO
Axelia Oncology

Aleta Knowles

Investment Manager
Uniseed

Paul Young

CEO
Ab Initio Pharma

Laura Issa

Strategic Advisor
Facio BioTherapies

Siro Perez

Head of Life Sciences
IP Group

Chris Alma

Director of
Cell & Gene Therapy
CSL

Lindsay Wu

Chief Science Officer
Proto Axiom

Brendon Boot

CEO
Skin2Neuron

Sharon Charles

VP Clinical Operations
ProPharma

Mike Lamprecht

Investment Manager,
Tenmile